203
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T78212 |
KRAS G12D inhibitor 18
KRAS G12D IN 18 |
Others | Others |
KRAS G12D inhibitor 18 为一种有效的 KRAS G12D 抑制剂,具有潜在的抗肿瘤和抑制肿瘤细胞增殖的活性,可用于研究胰腺癌。 | |||
T8756 |
KRAS inhibitor-9
DUN09716 |
Apoptosis; Ras | Apoptosis; GPCR/G Protein; MAPK |
KRAS inhibitor-9 (DUN09716) 是一种 KRAS 抑制剂,阻止 GTP-KRAS 的形成和 KRAS 下游激活。它以中等的结合亲和力与 KRAS G12D、KRAS G12C 和 KRAS Q61H 蛋白结合,选择性抑制具有 KRAS 突变的 NSC-LC 细胞的增殖。它可导致 G2/M 细胞周期停滞并诱导凋亡。 | |||
T40286 |
KRAS G12C inhibitor 19
|
Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 19 是一种有效的 KRAS G12C 抑制剂,在细胞实验中显示出抗肿瘤活性,科抑制肿瘤生长。 | |||
T38936 |
KRAS G13D peptide, 25 mer
KRAS G13D peptide, 25 mer |
||
KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a KRAS vaccine. | |||
T62228 |
KRAS G12D inhibitor 14
|
Ras | GPCR/G Protein; MAPK |
KRAS G12D inhibitor 14 是一种 KRAS G12D 的有效抑制剂,能够结合 KRAS G12D 蛋白 (Kd: 33 nM)。KRAS G12D inhibitor 14 抑制 KRAS G12D (KRAS G12D-GTP) 的活性形式,但对 KRAS G13D 无抑制作用。 | |||
T36761 | KRAS inhibitor-10 | ||
KRAS inhibitor-10 (WO2021005165 A1, compound 11) is a potent and selective inhibitor of RAS proteins, with a specific focus on KRAS proteins. This orally active anti-cancer agent demonstrates strong efficacy in cancer research, specifically in pancreatic cancer, breast cancer, multiple myeloma, leukemia, and lung cancer. KRAS inhibitor-10 is classified as a tetrahydroisoquinoline compound. Its inhibitory properties provide valuable insights and potential therapeutic applications in the field of ... | |||
T40282 | KRAS G12D inhibitor 7 | ||
KRAS G12D inhibitor 7, is a highly potent inhibitor specifically targeting KRAS G12D. | |||
T11774 |
KRAS inhibitor-7
|
Ras | GPCR/G Protein; MAPK |
KRAS inhibitor-7 is a potent KRAS G12C inhibitor. | |||
T11775 |
KRAS inhibitor-8
|
Ras | GPCR/G Protein; MAPK |
KRAS inhibitor-8 is a potent KRAS G12C inhibitor. | |||
T11772 | KRAS inhibitor-4 | Others | Others |
KRAS inhibitor-4 developed as anticancer agents, is a potent KRAS inhibitor. | |||
T77808 |
Kras binder 12
|
||
T40285 |
KRAS G12C inhibitor 18
|
||
KRAS G12C inhibitor 18 is a potent, orally active compound that inhibits KRAS G12C and exhibits anti-tumor activities. | |||
T11773 |
KRAS inhibitor-6
|
Ras | GPCR/G Protein; MAPK |
KRAS inhibitor-6 is a potent KRAS G12C inhibitor. | |||
T77806 |
KRAS inhibitor FB9
|
||
T40281 |
KRAS G12D inhibitor 6
|
||
KRAS G12D inhibitor 6 is an efficacious compound that effectively inhibits KRAS G12D. | |||
T40246 |
KRAS G12D inhibitor 5
|
||
KRAS G12D inhibitor 5 is a KRAS G12D inhibitor for the potential treatment of pancreatic cancer. | |||
T40272 |
KRAS mutant protein inhibitor 1
|
||
KRAS mutant protein inhibitor 1 is a KRAS mutant protein inhibitor for potential treatment in cancer. | |||
T9674 | KRAS G12D inhibitor 1 | ||
KRAS G12D inhibitor 1 (例 243) 是一种KRAS G12D 抑制剂,对KRAS G12D 介导的 ERK 磷酸化的IC50值为0.8 nM。 | |||
T11779 | KRas G12C inhibitor 4 | Ras | GPCR/G Protein; MAPK |
KRas G12C inhibitor 4 is a compound that inhibits KRas G12C. | |||
T11778 | KRas G12C inhibitor 3 | Ras | GPCR/G Protein; MAPK |
KRas G12C inhibitor 3 is a compound that inhibits KRas G12C. | |||
T11769 | KRAS G12C inhibitor 15 | Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor . | |||
T11780 |
KRAS G12C inhibitor 5
|
Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 5 is a KRas G12C inhibitor. | |||
T11771 |
KRAS G12C inhibitor 17
|
Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor. | |||
T11768 |
KRAS G12C inhibitor 14
|
Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 14 是一种有效的 KRAS G12C 抑制剂(IC50= 18 nM)。 | |||
T11767 |
KRAS G12C inhibitor 13
|
Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 13 is a KRAS G12C inhibitor . | |||
T11776 |
KRas G12C inhibitor 1
|
Ras | GPCR/G Protein; MAPK |
KRas G12C inhibitor 1 is a compound that inhibits KRas G12C. | |||
T11770 |
KRAS G12C inhibitor 16
|
Ras | GPCR/G Protein; MAPK |
KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor. | |||
T11777 | KRas G12C inhibitor 2 | Ras | GPCR/G Protein; MAPK |
KRas G12C inhibitor 2 is a compound that inhibits KRas G12C. | |||
T77802 |
KRAS G12C inhibitor 1R
|
||
T77804 |
KRAS G12D mutation regulator 4
|
||
T77805 |
KRAS G12C mutant protein inhibitor A-1
|
||
T78651 |
Glecirasib
JAB-21822,KRAS G12C inhibitor 36 |
Ras | GPCR/G Protein; MAPK |
Glecirasib (KRAS G12C inhibitor 36) 作为潜在的KRAS G12C抑制剂,在Ras蛋白家族中发挥作用,对细胞内信号传递具重要影响,并在生长发育中扮演关键角色。本化合物显示出研究KRAS G12C介导的癌症潜力。 | |||
T63928 | KRAS inhibitor-21 | ||
KRAS inhibitor-21 (22b) 是 KRAS G12C 抑制剂 (IC50<0.01 μM),能够用于研究癌症。 | |||
T62737 |
KRAS inhibitor-15
|
||
KRAS inhibitor-15 (compound 3-19) 是一种 KRAS G12C 的有效抑制剂 (IC50: 0.954 μM)。KRAS inhibitor-15 在 MIA PaCA-2,A549 细胞中表现出 p-ERK 抑制作用,IC50s 分别为 2.03,>33.3 μM。KRAS inhibitor-15 具有潜力进行胰腺癌、结直肠癌和肺癌的研究。 | |||
T63164 | KRAS inhibitor-13 | ||
KRAS inhibitor-13 (compound 5-6) 是一种 KRAS G12C 的有效抑制剂 (IC50: 0.883 μM)。KRAS inhibitor-13 在 MIA PaCA-2,A549 细胞中具有 p-ERK 抑制效果,其 IC50 值分别为 5.9,>100 μM。 KRAS inhibitor-13 具有潜力进行胰腺癌、结直肠癌和肺癌的研究。 | |||
T79147 |
KRAS degrader-1
|
||
KRAS degrader-1(compound 1)是通过自噬-溶酶体途径降解特定蛋白的高效KRAS降解剂。 | |||
T72659 |
KRAS inhibitor-3
|
||
KRAS inhibitor-3,一种高效KRAS抑制剂,具有强大的亲和力,能够与野生型及致癌型KRAS突变体紧密结合(KD值:KRAS WT为0.28 μM,KRAS G12C为0.63 μM,KRAS G12D为0.37 μM,KRAS Q61H为0.74 μM)。该化合物还能干扰KRAS与Raf之间的相互作用。 | |||
T72599 |
KRAS inhibitor-11
|
||
KRAS inhibitor-11 是一种 KRAS 抑制剂。 | |||
T63235 | KRAS inhibitor-14 | ||
KRAS inhibitor-14 是 KRAS G12C 的有效抑制剂(IC50: 0.249 μM)。KRAS inhibitor-14 在 MIA PaCA-2,A549 细胞中表现出 p-ERK 抑制作用,IC50s 分别为 1.12,>33.3 μM。KRAS inhibitor-14 对胰腺癌、结直肠癌和肺癌的具有研究潜力。 | |||
T62981 | KRAS inhibitor-17 | ||
KRAS inhibitor-17 (compound 3-9) 是一种 KRAS G12C 的有效抑制剂 (IC50: 3.37 μM)。KRAS inhibitor-17 具有 p-ERK 抑制作用,在 MIA PaCA-2 细胞的 IC50=9.25 μM,在 A549 细胞中的 IC50 >33.3 μM。KRAS inhibitor-17 具有潜力进行胰腺癌,结直肠癌和肺癌的研究。 | |||
T62751 | KRAS inhibitor-12 | ||
KRAS inhibitor-12 (compound 6-1) 是一种 KRAS G12C 的有效抑制剂 (IC50: 0.537 μM)。KRAS inhibitor-12 在 MIA PaCA-2,A549 细胞中表现出 p-ERK 抑制作用,其 IC50 值分别为 1.3,3.7 μM。 KRAS inhibitor-12 具有潜力进行胰腺癌,结直肠癌和肺癌的研究。 | |||
T62752 | KRAS inhibitor-16 | ||
KRAS inhibitor-16 (compound 3-11) 是一种 KRAS G12C 的有效抑制剂 (IC50: 0.457 μM)。KRAS inhibitor-16 在 MIA PaCA-2,A549 细胞中表现出 p-ERK 抑制作用,IC50s 分别为 3.06,11.1 μM。 KRAS inhibitor-16 具有潜力进行胰腺癌,结直肠癌和肺癌的研究。 | |||
T62784 |
KRAS inhibitor-18
|
||
KRAS inhibitor-18 (compound 3-10) 是一种 KRAS G12C 的有效抑制剂 (IC50: 4.74 μM)。KRAS inhibitor-18 在 MIA PaCA-2,A549 细胞中表现出 p-ERK 抑制作用,IC50s 分别为 66.4,11.1 μM。KRAS inhibitor-18 具有潜力进行胰腺癌、结直肠癌和肺癌的研究。 | |||
T79800 |
pan-KRAS-IN-2
|
Ras | GPCR/G Protein; MAPK |
Pan-KRAS-IN-2(compound 6)是一种抑制剂,对KRAS WT及其多种突变体(G12D、G12C、G12V、G12S、G12A、Q61H)表现出极高的抑制活性,其IC50均不超过10 nM;然而对KRAS G13D的抑制活性较低,IC50超过10 μM。 | |||
T79162 | SOS1/KRAS-IN-1 | Ras | GPCR/G Protein; MAPK |
SOS1/KRAS-IN-1(Compound 2)为针对SOS1/KRAS介导的疾病进行研究而设计的抑制剂。 | |||
T64142 |
KRAS G12C inhibitor 46
|
||
KRAS G12C inhibitor 46 是一种 KRAS G12C 的有效抑制剂。 | |||
T63807 | KRAS G12C inhibitor 33 | ||
KRAS G12C inhibitor 33 是 KRAS G12C 抑制剂,能够用于研究癌症。 | |||
T63501 | KRAS G12C inhibitor 30 | ||
KRAS G12C inhibitor 30 是 KRAS G12C 的抑制剂,能够用于研究癌症。 | |||
T63577 |
KRAS G12D inhibitor 11
|
||
KRAS G12D inhibitor 11 是 KRAS G12D 的有效抑制剂。其中 Ras 蛋白家族是重要的细胞内信号分子,在生长发育中起重要作用。KRAS G12D inhibitor 11 对 KRAS G12D 介导的癌症表现出研究潜力。 | |||
T72394 | KRAS G12D inhibitor 3 | ||
KRAS G12D inhibitor 3 是一种KRAS G12D 抑制剂,其IC50小于500 nM,具有抗肿瘤作用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S0777 |
Phellodendrine chloride
|
Others | Others |
Phellodendrine chloride 是一种Phellodendron amurense 中的生物碱。它通过巨胞饮抑制营养物质的吸收,进而抑制 KRAS 突变的胰腺癌细胞的增殖。 |